Company intelligence / Profile preview

The9 Limited

Shanghai, China

Ownership: Private
Development stage: Other

Overview

The9 Limited is primarily an internet and technology company that has been making strategic investments in various sectors including AI applications, blockchain/cryptocurrency mining, and recently into life sciences through investee companies. The company itself does not develop therapeutic products.

Industry: Investors

Partnerships

Investment in GenAI LLM digital precision medicine platform for brain disease with WM TherapeuticInvestee company Nanyang Biologics focused on AI-powered drug discovery, merging with RF Acquisition Corp II19% stake acquisition in AI-powered educational technology company Wuhan Weixiang Science And Technology with option for additional 51%

Beyond the preview

Go deeper on The9 Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The9 Limited.

Explore the full profile